Dendritic Cells Subsets Profiles in Classical Hodgkin Lymphoma at Diagnosis and upon Treatment Completion: Analysis on 54 Patients

被引：0
|
作者：
Galati, Domenico
Zanotta, Serena
Corazzelli, Gaetano
Dario, Bruzzese
Capobianco, Gaetana
Morelli, Emanuela
Arcamone, Manuela
Frigeri, Ferdinando
De Filippi, Rosaria
Pinto, Antonio
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4095
引用
收藏
页数：3
相关论文
共 50 条
  • [21] TREATMENT HETEROGENEITY OF HIGH-RISK CLASSICAL HODGKIN LYMPHOMA IN PEDIATRIC AND AYA PATIENTS
    Kamat, Aarti
    Goldman, Joshua
    King, Madeleine
    Walling, Emily
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S60 - S60
  • [22] Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure
    Epperla, Narendranath
    Costa, Luciano J.
    Vaughn, John L.
    Hanel, Walter
    Raya, Saba
    Cashen, Amanda F.
    Sarmad, Rehan
    Badar, Talha
    Hamadani, Mehdi
    Liu, Yang
    Barta, Stefan K.
    Caimi, Paolo
    Sethi, Tarsheen K.
    Reddy, Nishitha
    Burkart, Madelyn
    Karmali, Reem
    Bello, Celeste
    Chavez, Julio C.
    Kothari, Shalin K.
    Hernandez-Ilizaliturri, Francisco J.
    Ballard, Hatcher J.
    Svoboda, Jakub
    Emery, Lukas
    Lansigan, Frederick
    Glenn, Martha
    Churnetski, Michael C.
    Cohen, Jonathon B.
    Sorge, Caryn
    Xavier, Ana C.
    BLOOD, 2019, 134
  • [23] Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America
    Gossen, Seisha Alana Von Glasenapp
    Martinez-Cordero, Humberto
    Villela, Luis
    Rocio Colunga-Pedraza, Perla
    Perez-Jacobo, Fernando
    Robles, Arianna
    Garces Paz, Diego Fernando
    Idrobo, Henry
    Castro, Denisse
    Rose Paredes, Sally
    Beltran, Brady E.
    Oliver, Ana Carolina
    Irigoin, Victoria
    Alejandro Ospina, Juan
    Oliday Rios, Rosa
    BLOOD, 2022, 140 : 9429 - 9430
  • [24] Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma
    Steidl, Christian
    Diepstra, Arjan
    Lee, Tang
    Chan, Fong Chun
    Farinha, Pedro
    Tan, King
    Telenius, Adele
    Barclay, Lorena
    Shah, Sohrab P.
    Connors, Joseph M.
    van den Berg, Anke
    Gascoyne, Randy D.
    BLOOD, 2012, 120 (17) : 3530 - 3540
  • [25] Survival of patients with classical Hodgkin lymphoma in Finland: a national population-based analysis
    Hannuksela, Noora
    Partanen, Anu
    Anttalainen, Anna
    Ukkola-Vuoti, Liisa
    Toppila, Iiro
    Vikkula, Johanna
    Marin, Katja
    Kuitunen, Hanne
    Miettinen, Tatu
    Kuittinen, Outi
    Ronka, Aino
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [26] Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients
    Marko Lucijanić
    Renata Huzjan Korunić
    Marija Ivić
    Amina Fazlić Džankić
    Željko Jonjić
    Zdravko Mitrović
    Željko Prka
    Mario Piršić
    Ozren Jakšić
    Petar Gaćina
    Josipa Vlasac Glasnović
    Vlatko Pejša
    Wiener klinische Wochenschrift, 2022, 134 : 80 - 82
  • [27] Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkin's lymphoma patients
    Lucijanic, Marko
    Korunic, Renata Huzjan
    Ivic, Marija
    Fazlic Dzankic, Amina
    Jonjic, Zeljko
    Mitrovic, Zdravko
    Prka, Zeljko
    Pirsic, Mario
    Jaksic, Ozren
    Gacina, Petar
    Glasnovic, Josipa Vlasac
    Pejsa, Vlatko
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (1-2) : 80 - 82
  • [28] Classical Hodgkin Lymphoma; RealWorld Observations from Physicians, Patients, and Caregivers on the Disease and Its Treatment (CONNECT): Physician First-Line Treatment Preferences for Stage III or IV Classical Hodgkin Lymphoma
    vens, Andrew M.
    Yu, Kristina S.
    Liu, Nicholas
    Surinach, Andy
    Holmes, Katie
    Flores, Carlos
    Kumar, Supriya
    Fanale, Michelle A.
    Flora, Darcy R.
    Parsons, Susan K.
    BLOOD, 2021, 138
  • [29] Treatment and Prognosis of lymphocyte-depleted classical Hodgkin lymphoma: a comprehensive analysis from the German Hodgkin Study Group
    Klimm, B.
    Franklin, J.
    Stein, H.
    Eichenauer, D. A.
    Haverkamp, H.
    Diehl, V
    Fuchs, M.
    Borchmann, P.
    Engert, A.
    ONKOLOGIE, 2011, 34 : 21 - 21
  • [30] Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin's lymphoma
    Nisbett, Alnecia R.
    Yang, Xiaoqin
    Squires, Patrick
    Gautam, Santosh
    Desai, Kaushal
    Raut, Monika
    Nahar, Akash
    FUTURE ONCOLOGY, 2022, 18 (32) : 3623 - 3636
12345